{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T13:27:13Z","timestamp":1770902833689,"version":"3.50.1"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"20","license":[{"start":{"date-parts":[[2021,5,21]],"date-time":"2021-05-21T00:00:00Z","timestamp":1621555200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>Fibrillary glomerulonephritis (FGN) is a diverse glomerular disease with poor renal prognosis. The optimal therapeutic approach remains undetermined, as treatment outcomes vary across different studies.<\/jats:p>\n            <jats:p>We retrospectively reviewed the medical data of 10 patients diagnosed with biopsy-proven FGN at our center between 2004 and 2019. Clinical and histological features, as well as therapeutic regimens and treatment response, are reported.<\/jats:p>\n            <jats:p>The patients were predominantly men (2.5\/1 men-female ratio) with a mean age at diagnosis of 46.5 years (IQR: 41.5-59.5). The median proteinuria and creatinine levels at presentation were 2.55\u200ag\/day (IQR: 0.4-8.9) and 1.35\u200amg\/dl (IQR: 0.94\u20131.88), respectively. Four out of 10 patients presented with nephrotic syndrome, 5 patients with nephritic syndrome and 1 with isolated microscopic hematuria. Light microscopy showed mesangial proliferative (n\u200a=\u200a7), membranoproliferative-like (n\u200a=\u200a2), and diffuse sclerosing patterns (n\u200a=\u200a1). Rituximab was used in 7\/10 patients, either as monotherapy (n\u200a=\u200a3) or combined with cyclophosphamide and corticosteroids (n\u200a=\u200a4). Patients who were treated with immunosuppression had higher median levels of creatinine (1.40\u200amg\/dl) and proteinuria (3.5\u200ag\/d) compared to those who received supportive treatment alone (0.94\u200amg\/dl and 0.6\u200ag\/d, respectively). After a median follow-up of 30 months (IQR:18\u201366.5), 4 out of 7 patients (57%) treated with immunosuppression achieved a clinical response, 1 had persistent renal dysfunction and 2 patients progressed to end-stage renal disease.<\/jats:p>\n            <jats:p>The present case series extends the existing literature on the clinical features and outcomes of FGN, as well as the use of rituximab-based regimens for the treatment of the disease. Further research is needed to establish the proper management of the disease.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000026022","type":"journal-article","created":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T15:06:14Z","timestamp":1621350374000},"page":"e26022","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":10,"title":["Clinicopathologic features and treatment outcomes of patients with fibrillary glomerulonephritis"],"prefix":"10.1097","volume":"100","author":[{"given":"Smaragdi","family":"Marinaki","sequence":"first","affiliation":[{"name":"Clinic of Nephrology and Renal Transplantation, National and Kapodistrian University of Athens Medical School, Laiko Hospital\u2019"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4189-9609","authenticated-orcid":false,"given":"Stathis","family":"Tsiakas","sequence":"additional","affiliation":[{"name":"Clinic of Nephrology and Renal Transplantation, National and Kapodistrian University of Athens Medical School, Laiko Hospital\u2019"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Liapis","sequence":"additional","affiliation":[{"name":"Department of Pathology, Laiko Hospital, Athens, Greece."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chrysanthi","family":"Skalioti","sequence":"additional","affiliation":[{"name":"Clinic of Nephrology and Renal Transplantation, National and Kapodistrian University of Athens Medical School, Laiko Hospital\u2019"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleni","family":"Kapsia","sequence":"additional","affiliation":[{"name":"Clinic of Nephrology and Renal Transplantation, National and Kapodistrian University of Athens Medical School, Laiko Hospital\u2019"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophia","family":"Lionaki","sequence":"additional","affiliation":[{"name":"Clinic of Nephrology and Renal Transplantation, National and Kapodistrian University of Athens Medical School, Laiko Hospital\u2019"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Boletis","sequence":"additional","affiliation":[{"name":"Clinic of Nephrology and Renal Transplantation, National and Kapodistrian University of Athens Medical School, Laiko Hospital\u2019"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,5,21]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1159\/000180846","article-title":"Nephrotic syndrome associated with amyloid-like glomerular deposits","volume":"18","author":"Rosenmann","year":"1977","journal-title":"Nephron"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0272-6386(12)70138-5","article-title":"Morphologic and clinical features of fibrillary glomerulonephritis vs immunotactoid glomerulopathy","volume":"22","author":"Fogo","year":"1993","journal-title":"Am J Kidney Dis"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1038\/ki.1992.433","article-title":"Clinical and pathologic features of fibrillary glomerulonephritis","volume":"42","author":"Iskandar","year":"1992","journal-title":"Kidney Int"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1046\/j.1523-1755.2003.00853.x","article-title":"Fibrillary and immunotactoid glomerulonephritis: distinct entities with different clinical and pathologic features","volume":"63","author":"Rosenstock","year":"2003","journal-title":"Kidney Int"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/oxfordjournals.ndt.a027409","article-title":"Clinical features, predictors of disease progression and results of renal transplantation in fibrillary\/immunotactoid glomerulopathy","volume":"11","author":"Pronovost","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"775","DOI":"10.2215\/CJN.08300910","article-title":"Fibrillary glomerulonephritis: a report of 66 cases from a single institution","volume":"6","author":"Nasr","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1046\/j.1523-1755.2002.00628.x","article-title":"Fibrillary glomerulonephritis and immunotactoid (microtubular) glomerulopathy are associated with distinct immunologic features","volume":"62","author":"Bridoux","year":"2002","journal-title":"Kidney Int"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1053\/j.ajkd.2013.03.031","article-title":"Long-term kidney disease outcomes in fibrillary glomerulonephritis: a case series of 27 patients","volume":"62","author":"Javaugue","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/ki.2014.408","article-title":"Diagnosis of monoclonal gammopathy of renal significance","volume":"87","author":"Bridoux","year":"2015","journal-title":"Kidney Int"},{"key":"R10-20250504","first-page":"63","article-title":"When the finding of glomerular fibrils in patients with nephrotic syndrome leads to an erroneous diagnosis","volume":"2","author":"Huerta","year":"2009","journal-title":"NDT Plus"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1053\/j.ajkd.2008.07.011","article-title":"Rituximab treatment of fibrillary glomerulonephritis","volume":"52","author":"Collins","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1093\/ndt\/gfu189","article-title":"Rituximab treatment for fibrillary glomerulonephritis","volume":"29","author":"Hogan","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"R13-20250504","first-page":"w13578","article-title":"Outcome of fibrillary glomerulonephritis","volume":"142","author":"Kalbermatter","year":"2012","journal-title":"Swiss Med Weekly"},{"key":"R14-20250504","article-title":"Treatment of fibrillary glomerulonephritis with rituximab: a 12-month pilot study [published online ahead of print, July 2, 2020]","author":"Erickson","year":"2020","journal-title":"Nephrol Dial Transplant"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"E9","DOI":"10.1053\/ajkd.2002.34933","article-title":"Fibrillary glomerulonephritis: early diagnosis associated with steroid responsiveness","volume":"40","author":"Dickenmann","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1159\/000440815","article-title":"End-stage kidney disease due to fibrillary glomerulonephritis and immunotactoid glomerulopathy outcomes in 66 consecutive ANZDATA registry cases","volume":"42","author":"Mallett","year":"2015","journal-title":"Am J Nephrol"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1681\/ASN.2007070757","article-title":"Fibrillary glomerulonephritis and immunotactoid glomerulopathy","volume":"19","author":"Alpers","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1159\/000455390","article-title":"Clinical features and outcomes of a racially diverse population with fibrillary glomerulonephritis","volume":"45","author":"Payan Schober","year":"2017","journal-title":"Am J Nephrol"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ekir.2017.07.017","article-title":"DNAJB9 is a specific immunohistochemical marker for fibrillary glomerulonephritis","volume":"3","author":"Nasr","year":"2018","journal-title":"Kidney Int Rep"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.ekir.2019.04.013","article-title":"Fibrillary glomerulonephritis: an update","volume":"4","author":"Rosenstock","year":"2019","journal-title":"Kidney Int Rep"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.kint.2019.01.024","article-title":"Serum levels of DNAJB9 are elevated in fibrillary glomerulonephritis patients","volume":"95","author":"Nasr","year":"2019","journal-title":"Kidney Int"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.kint.2019.03.021","article-title":"New developments in the diagnosis of fibrillary glomerulonephritis","volume":"96","author":"Nasr","year":"2019","journal-title":"Kidney Int"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000026022","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T06:22:39Z","timestamp":1746339759000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000026022"}},"subtitle":["A case series"],"short-title":[],"issued":{"date-parts":[[2021,5,21]]},"references-count":22,"journal-issue":{"issue":"20","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000026022","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,21]]},"assertion":[{"value":"2021-01-12","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-04-25","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}